Semaglutide is commonly prescribed to men and women with a Body Mass Index (BMI) of 30 or above, or those with a BMI of 27 or higher who also have high blood pressure, type 2 diabetes, high cholesterol, or other health issues that make losing weight challenging
Starting low allows the body to adapt to triple receptor activation gradually
The next major M&A opportunity may involve companies with differentiated oral GLP-1 assets, GLP-1/GIP dual agonists, amylin combinations, long-acting dosing platforms, or MASH-relevant metabolic therapies
Stick with chicken breast, white fish, shrimp, turkey, eggs, Greek yogurt, cottage cheese, tofu, tempeh, and legumes